More extensive in vivo research is thus needed to determine whether reduction of neuroinflammation and/or neuro-regeneration is the key mechanism by which PDE7 inhibition ameliorates ischemic stroke outcome. The gene discussed is PDE7A; the disease is ischemic stroke.